logo
Plus   Neg
Share
Email

Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates

Vertex Pharmaceuticals Inc. (VRTX) reported a profit for its second quarter that increased from the same period last year.

The company's profit totaled $837.27 million, or $3.18 per share. This compares with $267.43 million, or $1.03 per share, in last year's second quarter.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $686.80 million or $2.61 per share for the period.

Analysts had expected the company to earn $2.07 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 61.7% to $1.52 billion from $0.94 billion last year.

Vertex Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q2): $686.80 Mln. vs. $327.27 Mln. last year.
-EPS (Q2): $2.61 vs. $1.26 last year.
-Analysts Estimate: $2.07
-Revenue (Q2): $1.52 Bln vs. $0.94 Bln last year.

-Guidance:
Full year revenue guidance: $5.7 to 5.9 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT